Comparing Two Treatments for Resistant Kawasaki Disease – Evidence Update for Parents
Compared with children who received a second dose of IVIG, children who received infliximab were more likely to have their fever end within 24 hours. Children who received infliximab also had shorter fevers and spent less time in the hospital than children who received a second dose of IVIG. Children who received infliximab were less likely to get anemia from the treatment. Anemia was the only serious side effect caused by either medicine. Signs of swelling in the heart’s arteries looked about the same for both treatments.
